Prostate cancer drug Erleada reduces risk of spread by 20 percent, study finds

Erleada, a prescription medicine, when used with hormone-blocking therapy six months before and after prostate surgery improved the…

The post Prostate cancer drug Erleada reduces risk of spread by 20 percent, study finds appeared first on TheCable.